98 related articles for article (PubMed ID: 791317)
21. Dual effects of 5-hydroxytryptamine on stable analogue of thromboxane A2-induced aggregation and release reaction in rabbit platelets.
Li BY; Zhou YC; Li WH
Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):171-4. PubMed ID: 10374646
[TBL] [Abstract][Full Text] [Related]
22. The effects of neuroleptic drugs on 5-hydroxytryptamine induced platelet aggregation in schizophrenic patients.
Orr MW; Knox JM; Allen R; Gelder MG; Grahame-Smith DG
Br J Clin Pharmacol; 1981 Mar; 11(3):255-9. PubMed ID: 6111333
[TBL] [Abstract][Full Text] [Related]
23. 5-hydroxytryptamine and platelet aggregation.
De Clerck FF; Herman AG
Fed Proc; 1983 Feb; 42(2):228-32. PubMed ID: 6822293
[TBL] [Abstract][Full Text] [Related]
24. The ralationship between changes in 5-HT induced platelet aggregation and clinical state in patients treated with fluphenazine.
Orr MW; Boullin DJ
Br J Clin Pharmacol; 1976 Oct; 3(5):925-8. PubMed ID: 973988
[TBL] [Abstract][Full Text] [Related]
25. The reliability of 5-hydroxytryptamine induced platelet aggregation responses in schizophrenic patients treated with neuroleptic drugs.
Knox JM; Orr MW; Allen R; Gelder MG; Grahame-Smith DG
Br J Clin Pharmacol; 1981 Mar; 11(3):261-3. PubMed ID: 6111334
[TBL] [Abstract][Full Text] [Related]
26. The actions of flupenthixol upon 5-hydroxytryptamine-induced aggregation and the uptake of 5-hydroxytryptamine and dopamine by human blood platelets.
Boullin DJ; Grimes RP; Orr MW
Br J Pharmacol; 1975 Dec; 55(4):555-7. PubMed ID: 2360
[TBL] [Abstract][Full Text] [Related]
27. A serotonin-induced N-glycan switch regulates platelet aggregation.
Mercado CP; Quintero MV; Li Y; Singh P; Byrd AK; Talabnin K; Ishihara M; Azadi P; Rusch NJ; Kuberan B; Maroteaux L; Kilic F
Sci Rep; 2013 Sep; 3():2795. PubMed ID: 24077408
[TBL] [Abstract][Full Text] [Related]
28. Platelet aggregation and chlorpromazine therapy.
Boullin DJ; Know JM; Peters JR; Orr MW; Gelder MG; Grahame-Smith DG
Br J Clin Pharmacol; 1978 Dec; 6(6):538-40. PubMed ID: 728326
[No Abstract] [Full Text] [Related]
29. Response to platelet-activating factor of platelets from patients with multiple sclerosis.
Khan SN; Belin J; Smith AD; Sidey M; Zilkha KJ
Acta Neurol Scand; 1985 Mar; 71(3):212-20. PubMed ID: 3993327
[TBL] [Abstract][Full Text] [Related]
30. An assessment of platelet aggregation induced by 5-hydroxytryptamine.
Hilton BP; Cumings JN
J Clin Pathol; 1971 Apr; 24(3):250-8. PubMed ID: 5573439
[TBL] [Abstract][Full Text] [Related]
31. Studies of platelet 5-hydroxytryptamine (serotonin) in storage pool disease and albinism.
Weiss HJ; Tschopp TB; Rogers J; Brand H
J Clin Invest; 1974 Aug; 54(2):421-33. PubMed ID: 4847252
[TBL] [Abstract][Full Text] [Related]
32. Quantification of the morphological reaction of platelets to aggregating agents and of its reversal by aggregation inhibitors.
Born GV; Dearnley R; Foulks JG; Sharp DE
J Physiol; 1978 Jul; 280():193-212. PubMed ID: 99512
[TBL] [Abstract][Full Text] [Related]
33. Aspirin at therapeutic concentrations does not affect 5-hydroxytryptamine uptake by platelets.
Drummond AH; MacIntyre DE; Olverman HJ
Br J Pharmacol; 1977 Apr; 59(4):661-2. PubMed ID: 858010
[TBL] [Abstract][Full Text] [Related]
34. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.
Vanags DM; Rodgers SE; Duncan EM; Lloyd JV; Bochner F
Br J Pharmacol; 1992 Aug; 106(4):917-23. PubMed ID: 1393289
[TBL] [Abstract][Full Text] [Related]
36. Effect of 1-aminoadamantanes on adenine nucleotide and serotonin storage in blood platelets.
Wesemann W; Muschalek G; Stöltzing H; von Pusch I; Paul N
Eur J Cell Biol; 1981 Dec; 26(1):158-67. PubMed ID: 7327177
[TBL] [Abstract][Full Text] [Related]
37. [Inhibition of serotonin-induced platelet aggregation by endothelins].
Takada A; Takada Y
Nihon Rinsho; 1992 Feb; 50(2):315-8. PubMed ID: 1613985
[TBL] [Abstract][Full Text] [Related]
38. Effects of aspirin and prostaglandin E2 on secondary phase aggregation responses of schizophrenic patients treated with chlorpromazine.
Boullin DJ; Orr MW
Br J Clin Pharmacol; 1976 Oct; 3(5):929-33. PubMed ID: 973989
[TBL] [Abstract][Full Text] [Related]
39. Unexpected effects of aurin tricarboxylic acid on human platelets.
Kinlough-Rathbone RL; Packham MA
Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
[TBL] [Abstract][Full Text] [Related]
40. Further characterization of human platelet activation in the absence of aggregation: phosphorylations of specific proteins and relationship with platelet secretion.
Nunez D; Levy-Toledano S
Thromb Haemost; 1984 Apr; 51(2):198-203. PubMed ID: 6429882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
